PEG-Interferon alfa-2b plus Ribavirin-Behandlung bei chronischer Hepatitis C

被引：0
|
作者：
机构：
来源：
Monatsschrift Kinderheilkunde | 2005年 / 153卷 / 12期
关键词：
D O I：
10.1007/s00112-005-1265-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1192 / 1193
页数：1
相关论文
共 50 条
  • [31] Cytokine levels in peripheral blood of chronic hepatitis C (CHC) patients pre- and post treatment with peg-interferon alfa-2b and ribavirin
    Kaligeros, K
    Arseniou, V
    Tsakalia, L
    Demonakou, M
    Lagoudakis, M
    Agioutantis, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
  • [32] Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy
    Lo Iacono, O
    Castro, A
    Diago, M
    Moreno, JA
    Fernandez-Bermejo, M
    Vega, P
    García, V
    Carbonell, P
    Sanz, P
    Borque, MJ
    García-Buey, L
    García-Monzón, C
    Pedreira, J
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (04) : 463 - 469
  • [33] Peginterferon alfa-2b plus ribavirin for retreatment of chronic hepatitis C
    Dalke, DD
    Donovan, J
    Mailliard, M
    Monsour, H
    GASTROENTEROLOGY, 2004, 126 (04) : A667 - A667
  • [34] Treatment with pegylated interferon alfa-2b in combination with ribavirin improved health-related quality of life compared with interferon alfa-2b plus ribavirin in chronic hepatitis C.
    Gish, R
    Rzowej, N
    Brooks, L
    Brass, C
    Weng, W
    HEPATOLOGY, 2002, 36 (04) : 582A - 582A
  • [35] Early HCV-RNA decline during treatment with PEG-interferon alfa-2b plus ribavirin or conventional interferon alfa 2b plus ribavirin: Analysis of 80 patients treated at a single center.
    Cornberg, M
    Hadem, J
    Bastuerk, M
    Tillmann, HL
    Schueler, A
    Kothe, N
    Jaeckel, E
    Trautwein, C
    Wedemeyer, H
    Manns, MP
    HEPATOLOGY, 2001, 34 (04) : 217A - 217A
  • [36] Peginterferon alfa-2b plus ribavirin for chronic hepatitis
    Cecil, BD
    LANCET, 2002, 359 (9302): : 263 - 264
  • [37] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [38] Safety, efficacy, and pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C.
    Kelly, DA
    Bunn, SK
    Apelian, D
    Baczkowski, A
    Gupta, S
    Laughlin, M
    Cohard, M
    HEPATOLOGY, 2001, 34 (04) : 342A - 342A
  • [39] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [40] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents
    Al Ali, Jaber
    Owayed, Salem
    Al-Qabandi, Wafa'a
    Husain, Khaled
    Hasan, Fuad
    ANNALS OF HEPATOLOGY, 2010, 9 (02) : 156 - 160
12345